Dr Anthony V D’Amico of Brigham and Women’s Hospital and Dr Claus G Roehrborn of University of Texas Southwestern Medical Center lead study that finds some drugs used to reduce hair loss in men can skew PSA test results and fail to give accurate assessment of prostate cancer risk; research is published in journal Lancet; drawing

Share This Post
Share this post: Share this post with the world.
  • TimesURL
  • Gatorpeeps
  • Muti
  • Twitter
  • Posterous
  • Facebook
  • laaik.it

Filed under: BaldnessMale Hair Loss

Like this post? Subscribe to my RSS feed and get loads more!